Use of methyl-CCNU and procarbazine in advanced malignant melanoma resistant to DTIC therapy

Cancer Treat Rep. 1977 Dec;61(9):1738-9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Dacarbazine / therapeutic use
  • Drug Evaluation
  • Drug Resistance
  • Humans
  • Melanoma / drug therapy*
  • Nitrosourea Compounds / therapeutic use*
  • Procarbazine / therapeutic use*
  • Semustine / therapeutic use*

Substances

  • Nitrosourea Compounds
  • Semustine
  • Procarbazine
  • Dacarbazine